Literature DB >> 11241048

Caveats when considering ketogenic diets for the treatment of pyruvate dehydrogenase complex deficiency.

T A Weber1, M R Antognetti, P W Stacpoole.   

Abstract

OBJECTIVES: We conducted a critical assessment of the use of diets high in fat and low in carbohydrate ("ketogenic") in the treatment of children with congenital lactic acidosis caused by mutations in the mitochondrial pyruvate dehydrogenase complex (PDC). STUDY
DESIGN: The dietary composition of 18 subjects (11 from literature sources and 7 previously unpublished cases) was analyzed for nutrient composition. The biochemical and clinical responses to a long-term ketogenic regimen were also evaluated.
RESULTS: There was lack of uniformity in the proportion of fat calories administered and in the fatty acid composition of the diets. Ketogenic diets are also generally high in protein, compared with the recommended dietary allowance for age. Patient response to these regimens also varied considerably.
CONCLUSIONS: Although ketogenic diets have become the standard of care for the treatment of PDC deficiency, data to support their use are based on a few uncontrolled case reports in which dietary composition varied widely. Furthermore, there are several theoretical reasons for concern about the long-term safety of high-fat, low-carbohydrate diets. A controlled, prospective evaluation of the risks and benefits of these regimens for patients with PDC deficiency is required to establish rational nutritional guidelines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241048     DOI: 10.1067/mpd.2001.111817

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

Review 1.  Ketogenic diets in patients with inherited metabolic disorders.

Authors:  S Scholl-Bürgi; A Höller; K Pichler; M Michel; E Haberlandt; D Karall
Journal:  J Inherit Metab Dis       Date:  2015-06-25       Impact factor: 4.982

2.  Thiamine-Responsive and Non-responsive Patients with PDHC-E1 Deficiency: A Retrospective Assessment.

Authors:  Sanne van Dongen; Ruth M Brown; Garry K Brown; David R Thorburn; Avihu Boneh
Journal:  JIMD Rep       Date:  2014-04-10

3.  A zebrafish model for pyruvate dehydrogenase deficiency: rescue of neurological dysfunction and embryonic lethality using a ketogenic diet.

Authors:  Michael R Taylor; James B Hurley; Heather A Van Epps; Susan E Brockerhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

4.  Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency.

Authors:  Francois-G Debray; Marie Lambert; Michel Vanasse; Jean-Claude Decarie; Jessie Cameron; Valeriy Levandovskiy; Brian H Robinson; Grant A Mitchell
Journal:  Eur J Pediatr       Date:  2006-03-22       Impact factor: 3.183

Review 5.  Role of dichloroacetate in the treatment of genetic mitochondrial diseases.

Authors:  Peter W Stacpoole; Tracie L Kurtz; Zongchao Han; Taimour Langaee
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

6.  Beneficial effect of feeding a ketogenic diet to mothers on brain development in their progeny with a murine model of pyruvate dehydrogenase complex deficiency.

Authors:  Lioudmila Pliss; Urvi Jatania; Mulchand S Patel
Journal:  Mol Genet Metab Rep       Date:  2016-04-22

7.  Mendeliome sequencing enables differential diagnosis and treatment of neonatal lactic acidosis.

Authors:  Walid Fazeli; Mert Karakaya; Peter Herkenrath; Anne Vierzig; Jörg Dötsch; Jürgen-Christoph von Kleist-Retzow; Sebahattin Cirak
Journal:  Mol Cell Pediatr       Date:  2016-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.